Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Frequently asked questions
What sector does Carmat (ALCAR) operate in?
Carmat belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Carmat (ALCAR) current stock price?
As of the latest data, Carmat stock price is €0.10, with a previous close of €0.10.
What is Carmat (ALCAR) current market capitalization?
Carmat market cap is approximately 6.36 million.
What is Carmat (ALCAR) Earnings Per Share (EPS)?
The trailing EPS is -€1.15.
Does Carmat (ALCAR) pay dividends?
No. Carmat does not pay a dividend.
What is Carmat (ALCAR) beta (volatility) score?
Carmat has a beta of 1.102, meaning its volatility is roughly in line with the market.